← Back to Search

Hearing Aid Enhancements for Hearing Loss

N/A
Recruiting
Led By Virginia A Best, PhD
Research Sponsored by Boston University Charles River Campus
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Normal-Hearing Subjects: 18 to 35 years of age, Audiometric thresholds that do not exceed 20 dB HL at any frequency from 250 to 8000 Hz, Able to provide informed consent and understand experimental instructions, Normal or corrected-to-normal vision
Hearing-Impaired Subjects: 18 to 80 years of age, Documented sensorineural hearing loss, Able to provide informed consent and understand experimental instructions, Normal or corrected-to-normal vision
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 4 hours
Awards & highlights

Study Summary

This trial is investigating whether three different approaches can improve hearing for people who use hearing aids. The approaches being tested are increased high-frequency audibility, speech envelope enhancement, and appropriate sound image externalization.

Who is the study for?
This trial is for adults with hearing loss. Young adults (18-35) must have normal hearing levels, while older participants (up to 80) should have sensorineural hearing loss. All must understand English, provide consent, and have normal or corrected vision.Check my eligibility
What is being tested?
The study tests if spatial perception and speech clarity in noisy environments can be improved for hearing aid users through increased high-frequency sounds, speech envelope enhancement, or better sound image externalization.See study design
What are the potential side effects?
There are no direct side effects mentioned for this trial as it involves non-invasive testing of different hearing aid settings rather than medication or surgery.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18-35, with normal hearing and vision (with or without correction), and can understand the study.
Select...
I am between 18-80 years old with sensorineural hearing loss and can see normally or with correction.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 4 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 4 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Externalization rating at baseline
Externalization rating post-intervention
Interaural time difference discrimination at baseline
+5 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Experimental conditionExperimental Treatment1 Intervention
Participants will be presented with sound stimuli under a number of experimental conditions that simulate different hearing-aid conditions.

Find a Location

Who is running the clinical trial?

Boston University Charles River CampusLead Sponsor
113 Previous Clinical Trials
11,941 Total Patients Enrolled
1 Trials studying Hearing Loss
40 Patients Enrolled for Hearing Loss
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
327 Previous Clinical Trials
178,096 Total Patients Enrolled
54 Trials studying Hearing Loss
19,730 Patients Enrolled for Hearing Loss
Virginia A Best, PhDPrincipal InvestigatorBoston University

Media Library

Hearing Aid Condition Clinical Trial Eligibility Overview. Trial Name: NCT05260307 — N/A
Hearing Loss Research Study Groups: Experimental condition
Hearing Loss Clinical Trial 2023: Hearing Aid Condition Highlights & Side Effects. Trial Name: NCT05260307 — N/A
Hearing Aid Condition 2023 Treatment Timeline for Medical Study. Trial Name: NCT05260307 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this clinical trial still open?

"As indicated on clinicaltrials.gov, this research endeavour is actively searching for willing participants. The study was initially posted on the 9th of March 2022 and recently amended in mid-November of 20202."

Answered by AI

How many participants are currently taking part in this investigation?

"Affirmative. Clinicaltrials.gov reflects the current search for applicants, beginning March 9th 2022 and updated most recently in November 16th 2022. This medical trial is recruiting 220 individuals at one facility."

Answered by AI

Is eligibility for this research limited to individuals younger than 45?

"This trial is seeking patients aged 18 and older, yet younger than 80 years of age."

Answered by AI

Do I meet the requirements to take part in this experiment?

"This medical trial seeks 220 participants with a chronological age between 18 and 80 who demonstrate some degree of hearing loss. Audiometric thresholds must be at or below 20 decibels in the range from 250 to 8000 hertz; additionally, patients' vision should either be normal or corrected-to-normal. Furthermore, those aged 18 to 35 need to provide informed consent and comprehend experimental instructions in order for their enrollment request to be accepted."

Answered by AI
~126 spots leftby Nov 2026